Anne Wojcicki's nonprofit TTAM acquires 23andMe for $305 million, ending the gene-testing pioneer's bankruptcy saga. The deal still faces state regulators' objections over genetic data control.

Office of the Utah Attorney General and the Utah Department of Commerce's Division of Consumer Protection are issuing a ...

A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe's co-founder and former chief executive, Anne Wojcicki.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s nonprofit acquires 23andMe.

Illumina sees new pharma interest, even as its business suffers several hits from NIH funding and a DOJ settlement.

According to Wojcicki, panda parenting, an answer to the flawed helicopter parenting style, is an approach that promotes independence, personal responsibility and healthy self-esteem; “Panda ...

TTAM Research Institute, formed by 23andMe’s co-founder and former CEO Anne Wojcicki, is now the new owner of substantially all of 23andMe’s assets.

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today ...

As part of the bankruptcy proceeding, 23andMe secured a buyer in June when TTAM Research Institute, a nonprofit led by 23andMe co-founder Anne Wojcicki, agreed to acquire the company for $305 million.